These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 22497462)

  • 21. [A turning point in the knowledge of the structure-function-activity relations of elastin].
    Alix AJ
    J Soc Biol; 2001; 195(2):181-93. PubMed ID: 11727705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of N-palmitoylated human growth hormone by in situ liquid-liquid extraction and MALDI tandem mass spectrometry.
    Sachon E; Nielsen PF; Jensen ON
    J Mass Spectrom; 2007 Jun; 42(6):724-34. PubMed ID: 17428000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined application of high resolution and tandem mass spectrometers to characterize methionine oxidation in a parathyroid hormone formulation.
    Pan C; Valente JJ; LoBrutto R; Pickett JS; Motto M
    J Pharm Sci; 2010 Mar; 99(3):1169-79. PubMed ID: 19711445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mass spectrometry for small molecule pharmaceutical product development: a review.
    Gillespie TA; Winger BE
    Mass Spectrom Rev; 2011; 30(3):479-90. PubMed ID: 21500245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Understanding the degradation pathway of a poorly water-soluble drug formulated in PEG-400.
    Kochling JD; Miao H; Young CR; Looker AR; Shannon M; Montgomery ER
    J Pharm Biomed Anal; 2007 Apr; 43(5):1638-46. PubMed ID: 17224256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding specificity of the ectodomain of the parathyroid hormone receptor.
    Drechsler N; Fröbel J; Jahreis G; Gopalswamy M; Balbach J; Bosse-Doenecke E; Rudolph R
    Biophys Chem; 2011 Mar; 154(2-3):66-72. PubMed ID: 21339037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative determination of solid-state forms of a pharmaceutical development compound in drug substance and tablets.
    Xie Y; Tao W; Morrison H; Chiu R; Jona J; Fang J; Cauchon N
    Int J Pharm; 2008 Oct; 362(1-2):29-36. PubMed ID: 18588963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liquid Chromatography-High Resolution Mass Spectrometry for Peptide Drug Quality Control.
    Zeng K; Geerlof-Vidavisky I; Gucinski A; Jiang X; Boyne MT
    AAPS J; 2015 May; 17(3):643-51. PubMed ID: 25716148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fast protein sequence determination with matrix-assisted laser desorption and ionization mass spectrometry.
    Schär M; Börnsen KO; Gassmann E
    Rapid Commun Mass Spectrom; 1991 Jul; 5(7):319-26. PubMed ID: 1841651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [High performance liquid chromatography/electrospray ionization mass spectrometric characterization of recombinant L-asparaginase II].
    Han J; Sheng LS; Yang ZY; Xiang BR; An DK
    Yao Xue Xue Bao; 2001 Jan; 36(1):46-50. PubMed ID: 12579860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural identification and characterization of potential degradants of zotarolimus on zotarolimus-coated drug-eluting stents.
    Chen Q; Zielinski D; Chen J; Nowak S; Zhou CC
    J Pharm Biomed Anal; 2009 Dec; 50(5):778-86. PubMed ID: 19581067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of novel rapamycin derivatives as low-level impurities in active pharmaceutical ingredients.
    Zech SG; Carr M; Mohemmad QK; Narasimhan NI; Murray C; Rozamus LW; Dalgarno DC
    J Antibiot (Tokyo); 2011 Sep; 64(9):649-54. PubMed ID: 21792211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A multidisciplinary approach to identify a degradation product in a pharmaceutical dosage form.
    Pan C; Guan J; Lin M
    J Pharm Biomed Anal; 2011 Mar; 54(4):855-9. PubMed ID: 21129882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of reaction mechanisms of drug degradation in the solid state: a kinetic study implementing ultrahigh-performance liquid chromatography and high-resolution mass spectrometry for thermally stressed thyroxine.
    Neu V; Bielow C; Schneider P; Reinert K; Stuppner H; Huber CG
    Anal Chem; 2013 Feb; 85(4):2385-90. PubMed ID: 23311729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Raman mapping of pharmaceuticals.
    Gordon KC; McGoverin CM
    Int J Pharm; 2011 Sep; 417(1-2):151-62. PubMed ID: 21194560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification, characterization and quantification of new impurities by LC-ESI/MS/MS and LC-UV methods in rivastigmine tartrate active pharmaceutical ingredient.
    Thomas S; Shandilya S; Bharati A; Paul SK; Agarwal A; Mathela CS
    J Pharm Biomed Anal; 2012 Jan; 57():39-51. PubMed ID: 21880452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Separation and characterization of the tryptic peptide mapping of recombinant bovine growth hormone by reversed-phase high-performance liquid chromatography electrospray mass spectrometry.
    Chang JP; Kiehl DE; Kennington A
    Rapid Commun Mass Spectrom; 1997; 11(12):1266-70. PubMed ID: 9276973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analytical control of genotoxic impurities in the pazopanib hydrochloride manufacturing process.
    Liu DQ; Chen TK; McGuire MA; Kord AS
    J Pharm Biomed Anal; 2009 Sep; 50(2):144-50. PubMed ID: 19427156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analytical challenges in drug counterfeiting and falsification-The NMR approach.
    Holzgrabe U; Malet-Martino M
    J Pharm Biomed Anal; 2011 Jun; 55(4):679-87. PubMed ID: 21232896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Degradation studies of pentoxifylline: Isolation and characterization of a novel gem-dihydroperoxide derivative as major oxidative degradation product.
    Mone MK; Chandrasekhar KB
    J Pharm Biomed Anal; 2010 Nov; 53(3):335-42. PubMed ID: 20466503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.